Page last updated: 2024-09-04

olmesartan and cyanoginosin lr

olmesartan has been researched along with cyanoginosin lr in 1 studies

Compound Research Comparison

Studies
(olmesartan)
Trials
(olmesartan)
Recent Studies (post-2010)
(olmesartan)
Studies
(cyanoginosin lr)
Trials
(cyanoginosin lr)
Recent Studies (post-2010) (cyanoginosin lr)
8411855541,5331900

Protein Interaction Comparison

ProteinTaxonomyolmesartan (IC50)cyanoginosin lr (IC50)
Tyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)0.0012
Protein phosphatase 1AHomo sapiens (human)0.003
Serine/threonine-protein phosphatase PP1-gamma catalytic subunitHomo sapiens (human)0.0302
Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoformHomo sapiens (human)0.0001
Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B Gallus gallus (chicken)0.0016

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ekins, S; Williams, AJ; Xu, JJ1

Other Studies

1 other study(ies) available for olmesartan and cyanoginosin lr

ArticleYear
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010